Index of reports
> Cases with Fatigue (56)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 56 Next >>
Possible Neulasta side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22
Patient: 67 year old female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Zantac
Indication: Pruritus
Ebastine
Dosage: 10 mg, unk
Indication: Faecaloma
Ebastine
Indication: Pruritus
Neulasta
Indication: Pruritus
Zofran
Dosage: 8 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Halaven
Dosage: unk
Indication: Faecaloma
Start date: 2012-06-19
Halaven
Dosage: 1.58 mg, unk
Indication: Pruritus
Start date: 2012-06-26
Zantac
Dosage: 50 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Zofran
Indication: Pruritus
Solu-Medrol
Dosage: 20 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Loratadine
Indication: Pruritus
Neulasta
Dosage: unk
Indication: Faecaloma
Solu-Medrol
Indication: Pruritus
Loratadine
Indication: Faecaloma
Other drugs received by patient: Acebutolol; Nexium
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from France on 2012-08-21
Patient: female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Solu-Medrol
Dosage: 20 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Neulasta
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Ebsatine
Indication: Faecaloma
Loratadine
Indication: Pruritus
Loratadine
Indication: Faecaloma
Ebsatine
Indication: Pruritus
Halaven
Dosage: 1.58 mg/day
Start date: 2012-06-26
Halaven
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-19
Zofran
Dosage: 8 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zantac
Dosage: 50 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Acebutolol; Nexium
Possible Neulasta side effects in female
Reported by a physician from France on 2012-08-15
Patient: female
Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster
Drug(s) suspected as cause:
Ebastine
Indication: Pruritus
Loratadine
Indication: Pruritus
Zantac
Dosage: 50mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zofran
Dosage: 8mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Neulasta
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Halaven
Dosage: 1.58mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Solu-Medrol
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 37.1 kg (81.6 pounds)
Reactions: Fatigue, Body Temperature Increased, Hypophagia, Heart Rate Increased, Oropharyngeal Pain, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg
End date: 2012-07-27
Neulasta
Dosage: 6 mg
End date: 2012-07-28
Doxorubicin HCL
Dosage: 100 mg
End date: 2012-07-27
Possible Neulasta side effects in 67 year old female
Reported by a physician from France on 2012-08-08
Patient: 67 year old female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Neulasta
Dosage: unk
Indication: Chemotherapy
Start date: 2012-06-27
Halaven
Dosage: 1.58 mg, unk
Start date: 2012-06-19
Ondansetron
Dosage: 8 mg, unk
Start date: 2012-06-26
Solu-Medrol
Dosage: 20 mg, unk
Start date: 2012-06-26
Zantac
Dosage: 50 mg, unk
Start date: 2012-06-26
Possible Neulasta side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-02
Patient: 71 year old female, weighing 74.0 kg (162.8 pounds)
Reactions: Fatigue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1020 mg, q3wk
Indication: Breast Cancer
Start date: 2009-12-09
End date: 2010-01-27
Neulasta
Dosage: 6 mg, q3wk
Indication: Premedication
Start date: 2009-12-09
End date: 2010-01-27
Neulasta
Indication: Colony Stimulating Factor Prophylaxis
Taxotere
Dosage: 128 mg, q3wk
Indication: Breast Cancer
Start date: 2009-12-09
End date: 2010-01-27
Other drugs received by patient: Dexamethasone; Aloxi; Mesna; Dexamethasone
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg milligram(s) subcutaneous
Indication: Chemotherapy
Ranitidine
Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: see image
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Paclitaxel
Dosage: see image
Indication: Breast Cancer
End date: 2011-07-05
Other drugs received by patient: (Docusate); (Biotene / 00203502 / )
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-25
Patient: female
Reactions: Pain, non-Alcoholic Steatohepatitis, Weight Increased, Anticoagulant Therapy, Fatigue, Fibromyalgia, Central Venous Catheterisation, Oedema Peripheral, Depression, Migraine, Back Pain, Pain in Extremity, Therapeutic Product Ineffective, Menopause, Hysterectomy, Swelling, Alopecia, Disability, Deep Vein Thrombosis, Mobility Decreased
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Chemotherapeutics
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-06-25
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Fatigue, Vomiting, Herpes Simplex, Bone Pain, Mucosal Dryness, Headache, Constipation, Hyperhidrosis, Decreased Appetite
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2011-12-28
End date: 2012-03-01
Taxotere
Indication: Breast Cancer
Start date: 2011-12-28
End date: 2012-03-01
Neulasta
Indication: Chemotherapy
Start date: 2011-12-29
Other drugs received by patient: Sipralexa / 01588501 /; Colecalciferol; Simvastatin
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue
Drug(s) suspected as cause:
Neulasta
Indication: Chemotherapy
Granisetron
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
End date: 2011-07-05
Ranitidine
Indication: Product Used FOR Unknown Indication
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-01
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Adverse event resulted in: death
Drug(s) suspected as cause:
Ranitidine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: unk
Administration route: Oral
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Dexamethasone
Dosage: unk
Paclitaxel
Dosage: 300 mg, 1/2 weeks
End date: 2011-07-05
Neulasta
Indication: Chemotherapy
Dexamethasone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Dosage: unk
Indication: Chemotherapy
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg, 1/2 weeks
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Other drugs received by patient: Docusate; Biotene DRY Mouth
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Dyspnoea, Chest Pain, Obstructive Airways Disorder, Sensation of Pressure
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk, sc
Indication: Chemotherapy
Dexamethasone
Dosage: 4 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone (Domperidone)
Dosage: 20 mg, unk, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg, unk, iv
Indication: Product Used FOR Unknown Indication
Dexamethasone Sodium Phosphate
Dosage: 20 mg, unk, iv
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315;300 mg, unk, iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Paclitaxel
Dosage: 315;300 mg, unk, iv
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk, iv
Other drugs received by patient: Biotene; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Fatigue, Chest Discomfort, Hypopnoea, Chest Pain
Drug(s) suspected as cause:
Ranitidine
Dosage: 50 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s) (1 day), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
(Chlorphenamine)
Dosage: 10 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s), subcutaneous
Indication: Chemotherapy
Dexamethasone
Dosage: 20 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-05
Paclitaxel
Dosage: 315 mg milligram(s) (2 week), intravenous
Indication: Breast Cancer
End date: 2011-07-05
Paclitaxel
Dosage: 315 mg milligram(s) (2 week), intravenous
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral, 20 mg, as needed, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) (1 day), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: (Biotene); Docusate
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-05-29
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole
Possible Neulasta side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-05-29
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Dosage: 315 mg, q2wk
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Motilium
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 300 mg, q2wk
Start date: 2011-06-21
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk
Indication: Product Used FOR Unknown Indication
Chlorpheniramine TAB
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Dexamethasone
Dosage: 20 mg, bid
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate; Biotene / 06680101 /
Possible Neulasta side effects in 48 year old female
Reported by a physician from United Kingdom on 2012-05-23
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 8mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Paclitaxel
Dosage: 300mg every two weeks
Start date: 2011-06-21
End date: 2011-07-05
Dexamethasone
Granisetron
Dosage: 2mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315mg every two weeks
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Neulasta
Indication: Chemotherapy
Other drugs received by patient: Biotene DRY Mouth Mouthwash; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-22
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Dyspnoea, Chest Discomfort, Fatigue, Chest Pain
Drug(s) suspected as cause:
Chlorpheniramine TAB
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Dosage: 300 mg, q2wk
End date: 2011-07-05
Dexamethasone
Dosage: 20 mg, unk
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg, unk
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Dexamethasone
Dosage: 4 mg, unk
Administration route: Oral
Ranitidine
Dosage: 50 mg, unk
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Biotene / 06680101 /; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Respiratory Depth Decreased, Product Substitution Issue, Dyspnoea, Fatigue, Chest Discomfort, Chest Pain, Obstructive Airways Disorder, Discomfort
Drug(s) suspected as cause:
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: 20 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s), subcutaneous
Indication: Chemotherapy
Chlorpheniramine TAB
Dosage: 10 mg (milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg milligram(s), intravenous
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Chest Discomfort, Fatigue, Dyspnoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Domperidone
Administration route: Oral
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Indication: Chemotherapy
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Domperidone
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: unk
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Paclitaxel
Dosage: unk
Start date: 2011-05-24
End date: 2011-07-05
Ranitidine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg every 2 weeks
Start date: 2011-05-24
End date: 2011-06-07
Neulasta
Indication: Chemotherapy
Other drugs received by patient: Docusate; Biotene DRY Mouth
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-11
Patient: female
Reactions: Fatigue, Pain
Drug(s) suspected as cause:
Tykerb
Dosage: 1250mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-13
Neulasta
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-14
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Chest Discomfort, Dyspnoea
Drug(s) suspected as cause:
Neulasta
Indication: Chemotherapy
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Granisetron
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Other drugs received by patient: Doxorubicin HCL; Docusate; Cyclophosphamide; Biotene
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female
Reactions: Chest Discomfort, Fatigue, Dyspnoea
Drug(s) suspected as cause:
Chlorpheniramine TAB
Dosage: 10 mg; ;iv
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg; sc
Indication: Chemotherapy
Dexamethasone Sodium Phosphate
Dosage: 20 mg; ;iv
Indication: Product Used FOR Unknown Indication
Domperidone (Domperidone)
Dosage: 20 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50 mg; iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg; ;iv, 300 mg;iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene - / 00203502 /
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Dyspnoea, Fatigue, Chest Discomfort, Chest Pain
Drug(s) suspected as cause:
Domperidone (Domperidone)
Dosage: 20 mg;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg;iv ; 300 mg;iv
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Paclitaxel
Dosage: 315 mg;iv ; 300 mg;iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Dexamethasone Sodium Phosphate
Dosage: 20 mg;iv
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg;sc
Indication: Chemotherapy
Granisetron
Dosage: 1 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50 mg;iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg;iv
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate; Biotene / 00203502 /
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue
Drug(s) suspected as cause:
Domperidone
Dosage: 20 mg, unk
Administration route: Oral
Chlorpheniramine Maleate
Dosage: 10 mg, unk
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Granisetron
Dosage: 1 mg, unk
Administration route: Oral
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk
Other drugs received by patient: Biotene; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-05-03
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Dyspnoea, Chest Discomfort
Drug(s) suspected as cause:
Ranitidine
Indication: Product Used FOR Unknown Indication
Neulasta
Indication: Chemotherapy
Granisetron
Dosage: 2mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 8mg per day
Administration route: Oral
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Start date: 2011-06-21
End date: 2011-07-05
Chlorpheniramine Maleate
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Dexamethasone
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene DRY Mouth Mouthwash
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-04-26
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Other drugs received by patient: Sulphamethizole; Omeprazole; Pinex; Valacyclovir Hydrochloride
Possible Neulasta side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Fatigue, Sepsis, Chest Pain, Thrombocytopenia, Myocardial Infarction, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Dosage: 100 mg
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Neulasta
Dosage: 6 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Vincristine
Dosage: 2 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Cyclophosphamide
Dosage: 1410 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine
Dosage: 1880 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Rituximab
Dosage: 705 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Metoclopramide; Cotrim; Aspirin; Tramadol HCL
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-04-19
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Febrile Neutropenia, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Other drugs received by patient: Pinex; Omeprazole; Valacyclovir Hydrochloride; Sulphamethizole
Possible Neulasta side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-04-12
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Chest Discomfort, Dyspnoea
Drug(s) suspected as cause:
Neulasta
Indication: Chemotherapy
Ranitidine
Dosage: 50 mg, unk
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: unk mg, unk
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Domperidone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: unk unk, bid
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Biotene / 06680101 /; Docusate
Possible Neulasta side effects in female
Reported by a pharmacist from Ireland on 2012-04-05
Patient: female
Reactions: Back Pain, Abdominal Discomfort, Fatigue, Nausea, Oral Infection, Bone Pain, Pharyngitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Docetaxel; Losec / 00661201 /; Zofran; KIN; Dexamethasone; Cyclophosphamide; Mycostatin; Valoid / 00014902 /
Page 1 Next >>
|